object
Mounjaro
Eli Lilly's tirzepatide-based drug for diabetes targeting GLP-1 and GIP receptors.
Most often with
- organisationNovo Nordisk 3
- objectZepbound 3
- objectOzempic 3
- organisationU.S. Food and Drug Administration 2
- organisationEli Lilly and Company 2
- organisationBMO Capital Markets 2
- objectWegovy 2
- objectretatrutide 2
- workJAMA Ophthalmology 1
- workClinicalTrials.gov 1
- placeUnited States 1
- placeUK 1
- placeStockholm 1
- placeOslo 1
- placeNew Delhi 1
- placeMilan 1